title: Effects of amiloride on intracellular pH and thermosensitivity.
abstract: Amiloride, a diuretic drug, is a potent inhibitor of Na+/H+ exchange through the plasma membrane, and has been reported to enhance thermal damage in tumor cells in vitro. We investigated the possible relationship between changes in the thermal response of SCK mouse mammary tumor cells in vitro and changes in intracellular pH (pHi) due to amiloride in the present study. At a concentration of 0.5 mM, amiloride reduced the shoulder (Dq) without causing significant change in the slope (Do) of the survival curve of SCK cells heated once at 43 degrees C. On the other hand, 0.5 mM of amiloride sensitized thermotolerant cells to heat as shown by a reduction in Do. The presence of amiloride during the interval between the first and second heatings slightly reduced or inhibited the development of thermotolerance. The pHi was measured with the BCECF fluorescence method. The presence of 0.5 mM amiloride significantly reduced pHi in both pH 7.2 and 6.6 medium. Heating the SCK cells at 43 degrees C in pH 7.2 or 6.6 medium also reduced the pHi. The combined effect of heat and amiloride in reducing the pHi of SCK cells was additive. These results suggest that the effects of amiloride on the thermal response of SCK cells might be mediated in part by a decrease in pHi. The possibility that the effects of amiloride on the thermal response of tumor cells are mediated by other biochemical changes, such as inhibition of protein synthesis, however, could not be ruled out.
authors.affiliation: Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota Medical School, Minneapolis 55455.
authors.forename: G E
authors.initials: GE
authors.lastname: Kim
authors.forename: J C
authors.initials: JC
authors.lastname: Lyons
authors.forename: C W
authors.initials: CW
authors.lastname: Song
mesh_terms: D000584:Amiloride / Q000494:pharmacology*; D000818:Animals; D001833:Body Temperature Regulation / Q000187:drug effects*; D002352:Carrier Proteins / Q000378:metabolism; D003131:Combined Modality Therapy; D005260:Female; D006863:Hydrogen-Ion Concentration / Q000187:drug effects*; D006979:Hyperthermia, Induced; D015674:Mammary Neoplasms, Animal / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D051379:Mice; D017923:Sodium-Hydrogen Exchangers; D013696:Temperature
chemical_list: D002352:Carrier Proteins; D017923:Sodium-Hydrogen Exchangers; D000584:Amiloride